Skip to content

Trachospray Device for Airway Anesthesia

Trachospray Device for Airway Anesthesia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON19975
Enrollment
20
Registered
2019-11-26
Start date
2019-12-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Subjects will be asked to inhale 4 ml lidocaine 4% via the Trachospray device

Sponsors

Radboud university medical center, Nijmegen, The Netherlands
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - Age between 18-60 years - ASA physical status 1

Exclusion criteria

Exclusion criteria: - Inability to cooperate with adequate airway assessment, - History of hepatic, renal and coagulation diseases, - Respiratory tract pathology - Pregnancy - Risk of regurgitation or aspiration - Allergy to amide type of local anesthetics - No written informed consent by subject

Design outcomes

Primary

MeasureTime frame
Complete anesthesia of the airway as evaluated and demonstrated by awake laryngobronchoscopy with minimal discomfort for the subject.

Contacts

Public ContactG.J. van Geffen

Radboudumc

Geert-Jan.vanGeffen@radboudumc.nl+3124 365 57 55

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)